tiprankstipranks
Trending News
More News >
Tourmaline Bio Announces Positive Phase 2 Trial Results
PremiumCompany AnnouncementsTourmaline Bio Announces Positive Phase 2 Trial Results
2M ago
Tourmaline Bio announces results from ongoing Phase 2 TRANQUILITY trial
Premium
The Fly
Tourmaline Bio announces results from ongoing Phase 2 TRANQUILITY trial
2M ago
Buy Rating for Tourmaline Bio: Anticipated Catalyst from Phase 2 TRANQUILITY Study on Pacibekitug
Premium
Ratings
Buy Rating for Tourmaline Bio: Anticipated Catalyst from Phase 2 TRANQUILITY Study on Pacibekitug
2M ago
Tourmaline Bio: Strong Financial Position and Promising Phase II Study Results Drive Buy Rating
PremiumRatingsTourmaline Bio: Strong Financial Position and Promising Phase II Study Results Drive Buy Rating
2M ago
Tourmaline Bio reports Q1 EPS (89c), consensus (94c)
Premium
The Fly
Tourmaline Bio reports Q1 EPS (89c), consensus (94c)
2M ago
Tourmaline Bio sees cash runway into 2H27
Premium
The Fly
Tourmaline Bio sees cash runway into 2H27
2M ago
Tourmaline Bio’s TOUR006: Potential Best-in-Class IL-6 Treatment with Strategic Market Positioning
PremiumRatingsTourmaline Bio’s TOUR006: Potential Best-in-Class IL-6 Treatment with Strategic Market Positioning
3M ago
Positive Buy Rating for Tourmaline Bio Driven by Promising Pacibekitug Developments and Strategic Value
Premium
Ratings
Positive Buy Rating for Tourmaline Bio Driven by Promising Pacibekitug Developments and Strategic Value
4M ago
Tourmaline Bio price target raised to $43 from $42 at Wedbush
Premium
The Fly
Tourmaline Bio price target raised to $43 from $42 at Wedbush
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100